HomeXRTX • NASDAQ
XORTX Therapeutics Inc
Follow
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 454.52K | -32.67% |
Net income | 122.54K | -95.46% |
Net profit margin | — | — |
Earnings per share | -0.81 | -26.71% |
EBITDA | -367.49K | 44.91% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.47M | -28.25% |
Total assets | 4.09M | -25.12% |
Total liabilities | 757.99K | -8.23% |
Total equity | 3.34M | — |
Shares outstanding | 3.28M | — |
Price to book | 0.93 | — |
Return on assets | -28.60% | — |
Return on capital | -40.80% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 122.54K | -95.46% |
Cash from operations | -886.41K | 31.71% |
Cash from investing | -4.04K | 58.80% |
Cash from financing | 1.11M | 454.53% |
Net change in cash | 172.90K | 110.66% |
Free cash flow | 47.06K | 104.34% |
Previous close
$0.95
Day range
$0.90 - $1.00
Year range
$0.82 - $3.92
Market cap
5.48M CAD
Avg Volume
54.91K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
About
Founded
2011
Headquarters
Website
Employees
3
